MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia
Hanqian L. Carlson, Thai T Nguyen, Samantha Tauchmann…·Julia E. Maxson
This study identifies MYST acetyltransferases as therapeutic targets in SETBP1-mutant leukemia, showing that MYST inhibitors reduce target gene expression and improve survival in mouse models.